News

Latest news

Hide mandatory notifications of trade
  • Share capital increase registered

    Financial .2016

    (Oslo, Norway, 11 October 2016) Reference is made to the stock exchange announcement dated 4 October 2016 concerning the final result of the rights issue (the “Rights Issue”) of 525,000,000 new shares in Bionor Pharma ASA (“Bionor” or the “Company”, ticker “BIONOR”) at a subscription price of NOK 0.10.

  • Mandatory notification of trade - Høie

    Financial .2016

    Lars Høie has on 4 October 2016 sold 10,150,000 shares and has also been allocated 113,870,152 new shares in the rights offering in Bionor Pharma ASA (the "Company").

  • Primary insider notification – Allocation overview

    Financial .2016

    (Oslo, Norway, 5 October 2016) Reference is made to the announcement on 14 September 2016 regarding the Rights Offering in Bionor Pharma ASA (the “Company”) and the announcement on 4 October 2016 regarding the final result of the Rights Offering.

  • Bionor Pharma – Final result of the rights issue

    Financial .2016

    (Oslo, Norway, 4 October 2016) Reference is made to previous stock exchange announcements and the prospectus (the “Prospectus”) dated 14 September 2016 concerning the rights issue (the “Rights Issue”) of 525,000,000 new shares at a subscription price of NOK 0.10 per share in Bionor Pharma ASA (“Bionor” or the “Company”, ticker “BIONOR”).

  • Bionor Pharma – Preliminary result of the rights issue

    Financial .2016

    (Oslo, Norway, 30 September 2016) Reference is made to previous stock exchange announcements and the prospectus (the “Prospectus”) dated 14 September 2016 concerning the rights issue (the “Rights Issue”) of 525,000,000 new shares at a subscription price of NOK 0.10 per share in Bionor Pharma ASA (“Bionor” or the “Company”, ticker “BIONOR”).

  • Mandatory Notification of Trade - Additional information warrants

    Financial .2016

    (Oslo, Norway, 29 September 2016) Reference is made to the announcement on 14 September 2016 regarding the Rights Offering in Bionor Pharma ASA (the “Company”).

  • Mandatory Notification of Trade - Jens Krøis

    Financial .2016

    (Oslo, Norway, 29 September 2016) Reference is made to the announcement on 14 September 2016 regarding the Rights Offering in Bionor Pharma ASA (the “Company”).

  • Expiry of subscription period and last day of trading in subscription rights today

    Financial .2016

    (Oslo, Norway, 29 September 2016) Reference is made to previous stock exchange announcements and the prospectus (the “Prospectus”) dated 14 September 2016 concerning the rights issue (the “Rights Issue”) of 525,000,000 new shares at a subscription price of NOK 0.10 per share in Bionor Pharma ASA (“Bionor” or the “Company”, ticker “BIONOR”).

  • Mandatory notification of trades - Lars Høie

    Financial .2016

    Lars Høie has on 28 September 2016 sold 25,000,000 shares, disposed of 1,500,000 Subscription Rights and exercised his remaining 96,199,303 Subscription Rights in the rights offering in Bionor Pharma ASA (the "Company").

  • Expiry of subscription period and last day of trading in subscription rights tomorrow

    Financial .2016

    (Oslo, Norway, 28 September 2016) Reference is made to previous stock exchange announcements and the prospectus (the “Prospectus”) dated 14 September 2016 concerning the rights issue (the “Rights Issue”) of 525,000,000 new shares at a subscription price of NOK 0.10 per share in Bionor Pharma ASA (“Bionor” or the “Company”, ticker “BIONOR”).